Krane Funds Advisors LLC reduced its position in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 86.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 510 shares of the company’s stock after selling 3,244 shares during the quarter. Krane Funds Advisors LLC’s holdings in Kimberly-Clark were worth $73,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Rise Advisors LLC lifted its holdings in Kimberly-Clark by 926.3% during the 1st quarter. Rise Advisors LLC now owns 195 shares of the company’s stock valued at $25,000 after buying an additional 176 shares in the last quarter. William B. Walkup & Associates Inc. bought a new position in Kimberly-Clark in the second quarter worth approximately $26,000. Crewe Advisors LLC purchased a new stake in shares of Kimberly-Clark during the 1st quarter worth $27,000. New Millennium Group LLC purchased a new stake in shares of Kimberly-Clark during the second quarter valued at about $28,000. Finally, Strategic Financial Concepts LLC acquired a new stake in Kimberly-Clark in the second quarter valued at approximately $32,000. 76.29% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Kimberly-Clark
In other news, insider Gonzalo Uribe sold 1,780 shares of Kimberly-Clark stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $140.84, for a total value of $250,695.20. Following the sale, the insider now directly owns 7,377 shares of the company’s stock, valued at $1,038,976.68. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, insider Gonzalo Uribe sold 1,780 shares of the stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now directly owns 7,377 shares in the company, valued at $1,038,976.68. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey P. Melucci sold 37,699 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the transaction, the insider now owns 19,935 shares in the company, valued at $2,819,207.70. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.62% of the company’s stock.
Kimberly-Clark Stock Up 0.1 %
Kimberly-Clark (NYSE:KMB – Get Free Report) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.25. The company had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $5.10 billion. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The firm’s revenue for the quarter was down 2.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.65 earnings per share. Analysts predict that Kimberly-Clark Co. will post 7.25 earnings per share for the current fiscal year.
Kimberly-Clark Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 2nd. Investors of record on Friday, September 6th were issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.34%. The ex-dividend date of this dividend was Friday, September 6th. Kimberly-Clark’s payout ratio is 89.71%.
Analyst Ratings Changes
Several equities research analysts have weighed in on KMB shares. TD Cowen initiated coverage on Kimberly-Clark in a report on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 price target for the company. Wells Fargo & Company dropped their target price on Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Kimberly-Clark from $146.00 to $147.00 and gave the stock a “hold” rating in a research report on Tuesday, October 8th. BNP Paribas started coverage on shares of Kimberly-Clark in a report on Monday, June 24th. They issued a “neutral” rating and a $146.00 price objective on the stock. Finally, StockNews.com cut shares of Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 30th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Kimberly-Clark currently has a consensus rating of “Hold” and an average price target of $149.14.
Read Our Latest Stock Report on Kimberly-Clark
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Further Reading
- Five stocks we like better than Kimberly-Clark
- ETF Screener: Uses and Step-by-Step Guide
- AI Boom Fuels Demand for Dominion Energy Stock
- What Is WallStreetBets and What Stocks Are They Targeting?
- Cathie Wood Cuts Robinhood Holdings—Follow Her Lead or Stay Put?
- What Are Dividends? Buy the Best Dividend Stocks
- Wave Life Sciences Rockets 70% on Historic RNA Editing Success
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.